Overview: Homocysteine Quantitative TestIntroduction: The Homocysteine Quantitative Test measures homocysteine levels to assess heart disease or vitamin deficiency risk, causing chest pain or fatigue. Aligned with 2023 AHA guidelines, it uses immunoassays for high accuracy, supporting cardiac screening. This test is critical for guiding cardiovascular risk assessment, vitamin supplementation, and improving outcomes in biochemistry for patients with suspected heart disease or metabolic issues.
Other Names: Homocysteine Assay, Plasma Homocysteine Test.
FDA Status: Laboratory-developed test (LDT), meeting biochemistry standards for diagnostic accuracy.
Historical Milestone: Homocysteine testing emerged in the 1990s with cardiovascular risk research. Immunoassay-based methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Measures homocysteine to assess heart disease or vitamin deficiency risk, guides treatment, and evaluates patients with chest pain or fatigue.
Test Parameters: 1. Homocysteine
Pretest Condition: Fasting for 10-12 hours required. Collect serum or plasma in the morning. Report history of heart disease, vitamin deficiencies, or family history of cardiovascular issues.
Specimen: 2-5 mL serum (SST) or 2-4 mL plasma (EDTA). Centrifuge within 1 hour. Transport in a biohazard bag.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document chest pain, fatigue, heart disease, or vitamin deficiencies (e.g., B6, B12, folate). Include current medications, especially statins or supplements.
Consent: Written consent required, detailing the tests purpose, cardiovascular or deficiency implications, and potential need for treatment planning.
Procedural Considerations: Uses immunoassays to measure homocysteine levels. Results are available in 1-2 days, supporting rapid clinical decisions. Performed in laboratories, often for cardiac or metabolic assessment.
Factors Affecting Result Accuracy: Non-fasting samples, improper handling, or certain medications (e.g., methotrexate) can affect results. Hemolysis may interfere with accuracy.
Clinical Significance: Elevated homocysteine indicates increased heart disease or vitamin deficiency risk, guiding supplementation or lifestyle changes. Normal levels suggest lower risk but require monitoring.
Specialist Consultation: Consult a cardiologist or endocrinologist for result interpretation and treatment planning.
Additional Supporting Tests: Lipid panel, vitamin B12, folate levels, or ECG to assess cardiovascular or metabolic health.
Test Limitations: Elevated homocysteine is not specific to heart disease; clinical correlation is needed. Lifestyle factors may influence results.
References: AHA Cardiovascular Guidelines, 2023; Clinical Chemistry, Refsum H, 2022.
